Bob became the 1,000th volunteer to join the READ-OUT trial, having attended ReMind UK with concerns about his memory. After being diagnosed with mild cognitive impairment (MCI), he chose to take part in the READ-OUT trial, a major national dementia research study exploring whether blood tests could help diagnose dementia earlier and more accurately. This important milestone shows the difference people can make by taking part in clinical research. The study is undertaking broad, nationwide blood sampling at 33 sites across the UK, including here at ReMind UK, to understand which biomarkers perform the best in diagnosing Alzheimer’s and non-Alzheimer’s dementias.
Reaching 1,000 participants is a fantastic achievement and reflects the generosity of people like Bob, who are willing to take part in research that could transform dementia diagnosis for future generations. Clinical trials are only possible because of our volunteers, and every participant brings us one step closer to earlier diagnosis, better treatments and improved outcomes for people affected by dementia."
Bob hopes that by sharing his story, more people will feel confident seeking help for memory concerns and consider taking part in research. Bob highlights, “What’s the point in sitting back and doing nothing? Research is vital to improving diagnosis, treatment and future care for people with Alzheimer’s disease, and I’m keen to help in any way I can.”
Memory Services at ReMind UK
At ReMind UK, we are proud to provide NHS memory services while leading pioneering dementia research that has the potential to change lives. Every clinical trial depends on people like Bob who are prepared to take part, but it also depends on charitable support to make that research possible.
Research Institute for Brain Health
ReMind UK aims to enable anyone wanting to take part in dementia research to enter a project which works for them. We are one of the few centres in the country with the level of expertise and required facilities to lead phase one and phase two novel treatment studies. Our staff are highly trained to care for older people and have the skills and experience needed to safely and efficiently manage treatment procedures, and over-night stays, putting those with a diagnosis first and in the best hands.
You can help dementia research
Register your interest to take part in a study or clinical trial
More news & views
What is the future of dementia research?
In July, London hosted the Alzheimer’s Association International Conference (AAIC), an annual conference dedicated to advancing dementia science and clinical practice.
Living with Alzheimer’s – Derek McCaig’s story
An Alzheimer’s diagnosis can bring uncertainty. What will life look like now? For Derek McCaig and his wife Sue, adapting to Alzheimer’s has meant making some changes but it has also meant continuing to stay active, social and involved in the things they enjoy.
What is Alzheimer’s disease
Alzheimer’s disease is the most common cause of dementia, affecting memory, thinking, behaviour, and the ability to carry out everyday activities. It is a progressive disease of the brain, which means symptoms gradually worsen over time.
Understanding Alzheimer’s can help reduce fear and stigma, and encourage people to seek advice early if they notice changes in themselves or someone they care about